Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Feb 9, 2024 | Uncategorized
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial Nov 27, 2023 | Uncategorized
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer Nov 27, 2023 | Uncategorized
Advances in clinical NK cell studies: Donor selection, manufacturing and quality control Jul 20, 2023 | Uncategorized
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies Jul 20, 2023 | Uncategorized
